Related Experiment Videos
[Autoreactive urticaria and autoimmune urticaria]
1Zentrum für Immundermatologie, Universitäts-Hautklink Mainz, Langenbeckstrasse 1, 55131 Mainz. maurer@hautklinik.klinik.uni-mainz.de
Summary
Autoreactive urticaria (ArU) involves histamine-releasing signals causing symptoms. Patients are identified by skin tests reacting to their own serum, distinguishing ArU and autoimmune urticaria (Aiu) from other chronic urticaria forms.
Area of Science:
- Immunology
- Dermatology
- Allergy and Clinical Immunology
Background:
- Chronic urticaria (CU) encompasses various subtypes with distinct underlying mechanisms.
- Autoreactive urticaria (ArU) is a subtype characterized by circulating histamine-releasing factors.
- Autoimmune urticaria (Aiu) involves autoantibodies targeting IgE or its receptor Fc(epsilon)RI.
Purpose of the Study:
- To differentiate autoreactive urticaria (ArU) and autoimmune urticaria (Aiu) from other chronic urticaria (CU) subtypes.
- To highlight the distinct pathogenesis and clinical presentation of ArU and Aiu.
Main Methods:
- Identification of ArU patients via the autologous serum skin test (ASST).
- Intracutaneous injection of patient serum to assess inflammatory reactions.
- Clinical and etiological assessment of CU patients with autoantibodies against IgE/Fc(epsilon)RI.
Main Results:
- ArU patients demonstrate positive reactions in the autologous serum skin test.
- Patients with autoantibodies against IgE and/or Fc(epsilon)RI are classified as Aiu.
- ArU and Aiu exhibit unique pathological pathways and clinical features compared to other CU forms.
Conclusions:
- Autoreactive urticaria and autoimmune urticaria represent distinct clinical entities within chronic urticaria.
- The autologous serum skin test is a key diagnostic tool for identifying ArU.
- Understanding these distinctions is crucial for accurate diagnosis and management of chronic urticaria subtypes.